Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tabassum DP"'
Autor:
Janiszewska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, USA., Tabassum DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Research Square, Durham, NC, USA., Castaño Z; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Cristea S; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Yamamoto KN; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Kingston NL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Murphy KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Harper NW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Del Alcazar CG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Ekram MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; WuXi NextCODE, Cambridge, MA, USA., Cohen O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Kwak M; Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA.; Yale Comprehensive Cancer Center, New Haven, CT, USA., Qin Y; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; EdiGene, Cambridge, MA, USA., Laszewski T; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Luoma A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA., Marusyk A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Cancer Imaging and Metabolism, Moffitt Cancer Center, Tampa, FL, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA., Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Fan R; Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA.; Yale Comprehensive Cancer Center, New Haven, CT, USA., Michor F; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., McAllister SS; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA. kornelia_polyak@dfci.harvard.edu.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Ludwig Center at Harvard, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, USA. kornelia_polyak@dfci.harvard.edu.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2024 May; Vol. 26 (5), pp. 841.
Autor:
Janiszewska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, USA., Tabassum DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Research Square, Durham, NC, USA., Castaño Z; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Cristea S; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Yamamoto KN; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Kingston NL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Murphy KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Harper NW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Del Alcazar CG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Ekram MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; WuXi NextCODE, Cambridge, MA, USA., Cohen O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Kwak M; Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA.; Yale Comprehensive Cancer Center, New Haven, CT, USA., Qin Y; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; EdiGene, Cambridge, MA, USA., Laszewski T; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Luoma A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA., Marusyk A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Cancer Imaging and Metabolism, Moffitt Cancer Center, Tampa, FL, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA., Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Fan R; Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA.; Yale Comprehensive Cancer Center, New Haven, CT, USA., Michor F; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., McAllister SS; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA. kornelia_polyak@dfci.harvard.edu.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Ludwig Center at Harvard, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, USA. kornelia_polyak@dfci.harvard.edu.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2019 Jul; Vol. 21 (7), pp. 879-888. Date of Electronic Publication: 2019 Jul 01.
Autor:
Marusyk A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Kornelia_polyak@dfci.harvard.edu andriy.marusyk@moffitt.org.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Tabassum DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; BBS Program, Harvard Medical School, Boston, Massachusetts., Janiszewska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Children's Hospital, Boston, Boston, Massachusetts., Trinh A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Rozhok AI; Department of Biochemistry and Molecular Genetics, University of Colorado, Aurora, Colorado., Pyne S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Guerriero JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Shu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Ekram M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Ishkin A; Thomson Reuters Healthcare & Science, Encinitas, California., Cahill DP; Massachusetts General Hospital, Boston, Massachusetts.; Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts., Nikolsky Y; Thomson Reuters Healthcare & Science, Encinitas, California., Chan TA; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York., Rimawi MF; Lester and Sue Smith Breast Center and the Dan L Duncan Comprehensive Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Hilsenbeck S; Lester and Sue Smith Breast Center and the Dan L Duncan Comprehensive Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Schiff R; Lester and Sue Smith Breast Center and the Dan L Duncan Comprehensive Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Osborne KC; Lester and Sue Smith Breast Center and the Dan L Duncan Comprehensive Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Kornelia_polyak@dfci.harvard.edu andriy.marusyk@moffitt.org.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; BBS Program, Harvard Medical School, Boston, Massachusetts.; Broad Institute, Cambridge, Massachusetts.
Publikováno v:
Cancer research [Cancer Res] 2016 Nov 15; Vol. 76 (22), pp. 6495-6506. Date of Electronic Publication: 2016 Sep 26.
Autor:
Shu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Lin CY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., He HH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts USA.; Princess Margaret Cancer Center/University Health Network, Toronto, Ontario, M5G1L7, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, M5G2M9, Canada., Witwicki RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Tabassum DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Roberts JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Janiszewska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Huh SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Liang Y; Princess Margaret Cancer Center/University Health Network, Toronto, Ontario, M5G1L7, Canada., Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Doherty E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard University, Cambridge, Massachusetts, USA., Mohammed H; Cancer Research UK, Cambridge Institute, University of Cambridge, UK, CB2 0RE., Guo H; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts USA., Stover DG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Ekram MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Brown J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., D'Santos C; Cancer Research UK, Cambridge Institute, University of Cambridge, UK, CB2 0RE., Krop IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Dillon D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, and Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA., McKeown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Ott C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Qi J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Ni M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Rao PK; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Duarte M; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wu SY; Simmons Comprehensive Cancer Center, Departments of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Chiang CM; Simmons Comprehensive Cancer Center, Departments of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Anders L; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Young RA; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Winer E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Barry WT; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts USA., Carroll JS; Cancer Research UK, Cambridge Institute, University of Cambridge, UK, CB2 0RE., Long H; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Liu XS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute, Cambridge, Massachusetts, USA., Meyer CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts USA., Bradner JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute, Cambridge, Massachusetts, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute, Cambridge, Massachusetts, USA.
Publikováno v:
Nature [Nature] 2016 Jan 21; Vol. 529 (7586), pp. 413-417. Date of Electronic Publication: 2016 Jan 06.
Autor:
Yoo B; Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Kavishwar A; Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Ross A; Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Wang P; Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Tabassum DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Barteneva N; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Petkova V; Molecular Medicine Core, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Pantazopoulos P; Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Tena A; Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts., Moore A; Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. zmedarova@partners.org amoore@helix.mgh.harvard.edu., Medarova Z; Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. zmedarova@partners.org amoore@helix.mgh.harvard.edu.
Publikováno v:
Cancer research [Cancer Res] 2015 Oct 15; Vol. 75 (20), pp. 4407-15. Date of Electronic Publication: 2015 Sep 10.
Autor:
Tabassum DP; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. [2] BBS Program, Harvard Medical School, Boston, Massachusetts 02115, USA., Polyak K; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. [2] BBS Program, Harvard Medical School, Boston, Massachusetts 02115, USA. [3] Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA. [4] Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.
Publikováno v:
Nature reviews. Cancer [Nat Rev Cancer] 2015 Aug; Vol. 15 (8), pp. 473-83. Date of Electronic Publication: 2015 Jul 02.
Autor:
Su Y; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Subedee A; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; BBS Program, Harvard Medical School, Boston, MA 02115, USA., Bloushtain-Qimron N; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA., Savova V; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA., Krzystanek M; Department of Systems Biology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark., Li L; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute Boston, MA 02215, USA., Marusyk A; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Tabassum DP; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; BBS Program, Harvard Medical School, Boston, MA 02115, USA., Zak A; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, MA 02215, USA., Flacker MJ; Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA., Li M; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA., Lin JJ; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Sukumar S; Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA., Suzuki H; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan., Long H; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute Boston, MA 02215, USA., Szallasi Z; Department of Systems Biology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark; Children's Hospital, Boston, MA 02115, USA., Gimelbrant A; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA., Maruyama R; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan. Electronic address: reomaru@sapmed.ac.jp., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; BBS Program, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; The Broad Institute, Cambridge, MA 02138, USA. Electronic address: kornelia_polyak@dfci.harvard.edu.
Publikováno v:
Cell reports [Cell Rep] 2015 Jun 16; Vol. 11 (10), pp. 1549-63. Date of Electronic Publication: 2015 Jun 04.
Autor:
Marusyk A; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA [3] Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA., Tabassum DP; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] BBS Program, Harvard Medical School, Boston, Massachusetts 02115, USA., Altrock PM; 1] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA [3] Program for Evolutionary Dynamics, Harvard University, Cambridge, Massachusetts 02138, USA., Almendro V; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA [3] Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA., Michor F; 1] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA., Polyak K; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA [3] Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA [4] BBS Program, Harvard Medical School, Boston, Massachusetts 02115, USA [5] Harvard Stem Cell Institute and the Broad Institute, Cambridge, Massachusetts 02138, USA.
Publikováno v:
Nature [Nature] 2014 Oct 02; Vol. 514 (7520), pp. 54-8. Date of Electronic Publication: 2014 Jul 30.